While the collective literature is encouraging, outcomes vary by model and methodology, and further controlled research may clarify scope, durability, and best-practice formulation parameters
The Lancet, 391(10132), 487-498
Managing the Combination Safely If your healthcare provider determines that you need both medications, there are steps you can take to manage the combination effectively
Future research should focus on exploring the regulatory mechanisms of SOD and CAT, particularly on how to restore antioxidant defense capabilities when the Nrf2 pathway is inhibited in order to halt the progression of OA
Similarly, the highly anticipated EVOKE and EVOKE+ phase 3 trials of oral semaglutide in early Alzheimers disease reported in November 2025 that semaglutide failed to meet its primary endpoints : while it reduced several AD-related biomarkers by up to 10%, these changes did not translate into cognitive or functional benefit ( [72] )